Improving Outcomes for Patients With Advanced Urothelial Carcinoma
Presented by Petros Grivas, MD, PhD, and Jeannette Hammond, PA-C
From University of Washington/Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, Seattle, Washington
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2020;11(3):285–289 |
© 2020 Harborside™
At JADPRO Live 2019, Petros Grivas, MD, PhD, and Jeannette Hammond, PA-C, reviewed data regarding mechanistic activity, efficacy, and safety of approved and emerging therapies for advanced or metastatic urothelial carcinoma, the selection of appropriate lines of therapy, and strategies for managing adverse events.
For access to the full length article, please sign in